Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,189 | 136 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $263.68 | 19 | $0 (2024) |
| Novo Nordisk Inc | $253.26 | 16 | $0 (2024) |
| PFIZER INC. | $228.20 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $189.55 | 12 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $145.16 | 3 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $139.61 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $138.68 | 9 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $113.63 | 7 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $83.99 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $78.45 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $752.68 | 44 | Novo Nordisk Inc ($169.74) |
| 2023 | $607.32 | 40 | Lilly USA, LLC ($133.28) |
| 2022 | $262.76 | 10 | Biohaven Pharmaceutical Holding Company Ltd. ($145.16) |
| 2020 | $11.96 | 1 | Merck Sharp & Dohme Corporation ($11.96) |
| 2019 | $128.92 | 10 | PFIZER INC. ($35.32) |
| 2017 | $425.18 | 31 | PFIZER INC. ($64.09) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.17 | General |
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Obesity | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Obesity | ||||||
| 08/07/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Bone Health | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Obesity | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,781 | 2,455 | $454,499 | $135,906 |
| 2022 | 16 | 941 | 1,352 | $345,909 | $107,647 |
| 2021 | 10 | 769 | 1,022 | $235,085 | $77,502 |
| 2020 | 11 | 932 | 1,305 | $275,212 | $81,974 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 278 | 455 | $142,624 | $36,783 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 270 | 270 | $86,505 | $34,147 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 115 | 135 | $59,566 | $16,436 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 192 | $42,553 | $11,878 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $38,691 | $11,287 | 29.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $7,781 | $3,080 | 39.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 35 | 92 | $9,164 | $2,606 | 28.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 30 | 30 | $3,481 | $2,274 | 65.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $5,324 | $2,103 | 39.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 112 | 112 | $5,040 | $2,016 | 40.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 202 | 211 | $7,326 | $1,946 | 26.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 28 | 38 | $5,999 | $1,886 | 31.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 50 | $2,000 | $1,476 | 73.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 37 | 38 | $4,905 | $1,398 | 28.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 19 | 19 | $3,927 | $1,393 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,634 | $1,353 | 29.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 23 | $3,165 | $886.72 | 28.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 45 | 46 | $1,610 | $568.10 | 35.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 13 | 23 | $1,842 | $553.64 | 30.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 48 | $1,682 | $473.86 | 28.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 13 | 13 | $1,470 | $450.06 | 30.6% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 14 | 14 | $716.40 | $286.44 | 40.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 34 | 61 | $686.25 | $210.04 | 30.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 39 | 203 | $4,760 | $161.92 | 3.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $236.50 | $92.40 | 39.1% |
About Dr. Benjamin Cameron, DO
Dr. Benjamin Cameron, DO is a Internal Medicine healthcare provider based in Longview, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1205248424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Cameron, DO has received a total of $2,189 in payments from pharmaceutical and medical device companies, with $752.68 received in 2024. These payments were reported across 136 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,189).
As a Medicare-enrolled provider, Cameron has provided services to 4,423 Medicare beneficiaries, totaling 6,134 services with total Medicare billing of $403,030. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Longview, TX
- Active Since 05/22/2014
- Last Updated 12/08/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205248424
Products in Payments
- NURTEC ODT (Drug) $214.56
- JARDIANCE (Drug) $182.67
- Rybelsus (Drug) $119.41
- TRELEGY ELLIPTA (Drug) $111.13
- SEGLENTIS (Drug) $91.92
- QUVIVIQ (Drug) $83.99
- Kerendia (Drug) $78.45
- ELIQUIS (Drug) $72.19
- Wegovy (Drug) $64.46
- TRULICITY (Drug) $61.91
- FARXIGA (Drug) $58.11
- JANUVIA (Drug) $50.25
- FORTEO (Drug) $45.89
- Ozempic (Drug) $41.84
- QULIPTA (Drug) $38.92
- UBRELVY (Drug) $36.55
- CHANTIX (Drug) $35.32
- EVENITY (Biological) $34.93
- BEVESPI AEROSPHERE (Drug) $34.04
- MOUNJARO (Drug) $33.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Longview
Dr. Matei Socoteanu, M.d, M.D
Internal Medicine — Payments: $43,107
Dr. Richard Kirkpatrick, M.d, M.D
Internal Medicine — Payments: $21,956
Dr. Justin Chen, M.d, M.D
Internal Medicine — Payments: $20,021
Dr. Brenda Vozza, Md, MD
Internal Medicine — Payments: $15,247
Dr. Helen Daniel-Glave, Md, MD
Internal Medicine — Payments: $8,759
Dr. Roger Pearce, Md, MD
Internal Medicine — Payments: $8,496